{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T02:47:07Z","timestamp":1773974827254,"version":"3.50.1"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001203","name":"GlaxoSmithKline Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001203","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.seizure.2019.11.011","type":"journal-article","created":{"date-parts":[[2019,11,25]],"date-time":"2019-11-25T11:37:05Z","timestamp":1574681825000},"page":"89-92","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Bidirectional interaction between oral contraception and lamotrigine in women with epilepsy \u2013 Role of progestins"],"prefix":"10.1016","volume":"74","author":[{"given":"Markus","family":"Rauchenzauner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Schirin","family":"Deichmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Pittschieler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie","family":"Bergmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuela","family":"Prieschl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iris","family":"Unterberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"R\u00f6sing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Seger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Moser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ludwig","family":"Wildt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerhard","family":"Luef","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.seizure.2019.11.011_bib0005","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.seizure.2007.11.012","article-title":"Pharmacokinetic interactions between contraceptives and antiepileptic drugs","volume":"17","author":"Sabers","year":"2008","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2019.11.011_bib0010","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1212\/01.WNL.0000044157.28073.DC","article-title":"Major malformations in offspring of women with epilepsy","volume":"60","author":"Kaaja","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2019.11.011_bib0015","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/j.1528-1157.1997.tb01480.x","article-title":"Maternal use of antiepileptic drugs and the risk of major congenital malformations: a joint European prospective study of human teratogenesis associated with maternal epilepsy","volume":"38","author":"Samren","year":"1997","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2019.11.011_bib0020","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1474-4422(11)70107-7","article-title":"Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry","volume":"10","author":"Tomson","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.seizure.2019.11.011_bib0025","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1136\/adc.2008.144386","article-title":"Changing trends in antiepileptic drug prescribing in girls of child-bearing potential","volume":"94","author":"Ackers","year":"2009","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.seizure.2019.11.011_bib0030","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1136\/adc.2009.176990","article-title":"Neurodevelopment of children exposed in utero to lamotrigine, sodium valproate and carbamazepine","volume":"96","author":"Cummings","year":"2011","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.seizure.2019.11.011_bib0035","doi-asserted-by":"crossref","first-page":"e831","DOI":"10.1212\/WNL.0000000000008001","article-title":"Declining malformation rates with changed antiepileptic drug prescribing: An observational study","volume":"93","author":"Tomson","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2019.11.011_bib0040","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/clpt.1987.193","article-title":"Lamotrigine, a new anticonvulsant: pharmacokinetics in normal humans","volume":"42","author":"Cohen","year":"1987","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.seizure.2019.11.011_bib0045","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1528-1167.2007.00997.x","article-title":"Oral contraceptives induce lamotrigine metabolism: evidence from a double-blind, placebo-controlled trial","volume":"48","author":"Christensen","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2019.11.011_bib0050","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1111\/j.1528-1167.2006.00558.x","article-title":"Variation in lamotrigine plasma concentrations with hormonal contraceptive monthly cycles in patients with epilepsy","volume":"47","author":"Contin","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2019.11.011_bib0055","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.seizure.2007.11.017","article-title":"Effects of pregnancy and contraception on lamotrigine disposition: new insights through analysis of lamotrigine metabolites","volume":"17","author":"Ohman","year":"2008","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2019.11.011_bib0060","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1212\/01.WNL.0000076485.09353.7A","article-title":"Oral contraceptives reduce lamotrigine plasma levels","volume":"61","author":"Sabers","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2019.11.011_bib0065","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1528-1157.1989.tb05316.x","article-title":"Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy","volume":"30","year":"1989","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2019.11.011_bib0070","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1212\/01.wnl.0000344167.78102.f0","article-title":"Valproate and lamotrigine level variation with menstrual cycle phase and oral contraceptive use","volume":"72","author":"Herzog","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2019.11.011_bib0075","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s00216-011-5612-0","article-title":"Simultaneous online SPE-LC-MS\/MS quantification of six widely used synthetic progestins in human plasma","volume":"403","author":"Moser","year":"2012","journal-title":"Anal Bioanal Chem"},{"key":"10.1016\/j.seizure.2019.11.011_bib0080","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1111\/j.1528-1167.2005.10105.x","article-title":"Ethinyl estradiol, not progestogens, reduces lamotrigine serum concentrations","volume":"46","author":"Reimers","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2019.11.011_bib0085","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.contraception.2015.07.008","article-title":"An educational intervention on drug interactions and contraceptive options for epilepsy patients: a pilot randomized controlled trial","volume":"93","author":"Mody","year":"2016","journal-title":"Contraception"},{"key":"10.1016\/j.seizure.2019.11.011_bib0090","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2147\/OAJC.S85541","article-title":"Contraception for women with epilepsy: counseling, choices, and concerns","volume":"7","author":"Reimers","year":"2016","journal-title":"Open Access J Contracept"},{"key":"10.1016\/j.seizure.2019.11.011_bib0095","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1212\/WNL.0b013e3181bd8295","article-title":"Lamotrigine kinetics within the menstrual cycle, after menopause, and with oral contraceptives","volume":"73","author":"Wegner","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2019.11.011_bib0100","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2165\/00002018-199309010-00003","article-title":"Oral contraceptives. Are drug interactions of clinical significance?","volume":"9","author":"Shenfield","year":"1993","journal-title":"Drug Saf"},{"key":"10.1016\/j.seizure.2019.11.011_bib0105","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1365-2125.2005.02539.x","article-title":"The pharmacokinetic and pharmacodynamic consequences of the co-administration of lamotrigine and a combined oral contraceptive in healthy female subjects","volume":"61","author":"Sidhu","year":"2006","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.seizure.2019.11.011_bib0110","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.seizure.2007.11.013","article-title":"Which contraception for women with epilepsy?","volume":"17","author":"Schwenkhagen","year":"2008","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2019.11.011_bib0115","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1136\/jnnp.72.1.114","article-title":"Antiepileptic drugs: coprescription of proconvulsant drugs and oral contraceptives: a national study of antiepileptic drug prescribing practice","volume":"72","author":"Shorvon","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Seizure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131119304236?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131119304236?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T01:53:58Z","timestamp":1761011638000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131119304236"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":23,"alternative-id":["S1059131119304236"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2019.11.011","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bidirectional interaction between oral contraception and lamotrigine in women with epilepsy \u2013 Role of progestins","name":"articletitle","label":"Article Title"},{"value":"Seizure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2019.11.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 British Epilepsy Association. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}